Brilinta (Ticagrelor)

Additional information

Brilinta  (Ticagrelor) is typically taken twice a day. However, your doctor or pharmacist may have suggested a different schedule that is more appropriate for you. It may be taken with or without food, at the same time everyday. Swallow the whole tablet with a full glass of water. For people that are unable to swallow tablets whole, the tablet can be crushed to a fine powder and mixed in half a glass of water. Drink immediately after mixing. Important: Follow the instructions on the label. Do not use more of this product, or more often than prescribed. If you miss a dose, contact your pharmacist. 

WARNING: Brilinta increases the risk of bleeding, which may be significant and sometimes fatal. This medication may cause slow heart rhythms (bradyarrhythmia). Use with caution in patients with certain abnormal heart rhythms (e.g., second or third-degree AV block, sick sinus syndrome, bradycardia-related syncope not protected by a pacemaker). Brilinta may cause an increase in the amount of uric acid in the blood. Use with caution in patients with a history of gout (a painful form of arthritis, which is the swelling and tenderness of one or more of your joints) or hyperuricemia (increase levels of uric acid in the blood). Maintenance doses of aspirin (more than 100 mg/day) in patients with acute coronary syndrome reduce the efficacy of Brilinta and should be avoided.

In addition to its desired action, Brilinta  (Ticagrelor) may cause some side effects, notably:
It may cause shortness of breath (dyspnea), fast, slow, or irregular heartbeat. 
It may cause nausea, diarrhea, constipation, or stomach pain. 
It may cause bleeding, dizziness, or elevated blood levels of creatinine (a waste product that comes from the normal wear and tear on muscles of the body).

Contraindications: Hypersensitivity to Ticagrelor or any component of the formulation. Patients with active bleeding, or with a history of intracranial hemorrhage (bleeding in the brain) should not use Brilinta  (Ticagrelor). 

Taking Brilinta  (Ticagrelor) during pregnancy may be harmful for the baby. Women of childbearing potential should use an effective contraceptive method. Pregnant women should not use this product. If you're planning a pregnancy or become pregnant or breastfeeding, contact your family doctor.

A treatment with Brilinta  (Ticagrelor) requires regular monitoring by a doctor. Be sure to see your doctor for all regularly scheduled appointments.Brilinta  (Ticagrelor)